Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Default Mode Network in Multiple Sclerosis Patients on Cladribine
2023-504577-21-00Phase 4Terminated
- Sponsor
- María Luisa Martínez Ginés
- Start
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of cladribine in multiple sclerosis (MS), sponsored by María Luisa Martínez Ginés. Started Jun 2023; status: terminated.
02
Drugs
cladribine
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on 2023-504577-21-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-504577-21-00.